Incyte appoints Cagnoni as President, integrates U.S. commercial; Trotta departs

INCYTE CORP

Pablo Cagnoni named President, Incyte and Global Head of R&D; replaces Bill Meury as President; Meury remains CEO.
Steven Stein promoted to EVP, Chief Medical Officer and Head of Late-stage Development.
Mohamed Issa becomes EVP and Head of U.S. Commercial; U.S. oncology and immunology teams integrated.
Matteo Trotta, EVP and GM of U.S. Dermatology, will leave Incyte after a transition period.
No changes to compensation for the impacted executives in connection with these title changes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.